Dr Reddys Laboratories RDY
NYSE RDY
$11.88 +0.00 (+0.00%)
As of: Sep 9, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Inventory Average (2009 - 2026)

Dr Reddys Laboratories (RDY) posted Inventory Average of $843.6 million for Q2 2026, down 2.16% on a QoQ basis from $862.2 million in Q1 2026, and down 1.0% year-over-year from $852.1 million in Q2 2025.

Analysis

Dr Reddys Laboratories (RDY) Inventory Average (2009 - 2026) Analysis & Trends

Dr Reddys Laboratories has reported Inventory Average for 18 years, with the latest figure at $843.6 million in Q2 2026.

  • On a quarterly basis, Inventory Average fell 1.0% year-over-year to $843.6 million in Q2 2026; TTM through Jun 2026 was $843.6 million, a 1.0% decrease from a year earlier, with the FY2026 full-year figure at $824.0 million, up 3.32% from the prior year.
  • Inventory Average was $843.6 million for Q2 2026 at Dr Reddys Laboratories, down from $862.2 million in the prior quarter.
  • The five-year high for Inventory Average was $878.2 million in Q4 2025, with the low at $596.4 million in Q1 2023.
  • Average Inventory Average over 5 years is $753.3 million, with a median of $770.7 million recorded in 2024.
  • The sharpest annual moves came in 2023 and 2024: Inventory Average decreased 10.96% in 2023, then gained 29.06% in 2024.
  • Over 5 years, Inventory Average stood at $608.0 million in 2022, then gained by 16.35% to $707.4 million in 2023, then climbed by 20.76% to $854.2 million in 2024, then gained by 2.81% to $878.2 million in 2025, then slipped by 3.95% to $843.6 million in 2026.
  • The last three Inventory Average figures came in at $843.6 million (Q2 2026), $862.2 million (Q1 2026), and $878.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 3.20 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 3.93 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 843.60 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 659.79 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 1.60 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 227.28 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 143.31 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 175.05 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn -
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 843.60 Mn
Mar 31, 2026 862.21 Mn
Dec 31, 2025 878.25 Mn
Sep 30, 2025 876.32 Mn
Jun 30, 2025 852.13 Mn
Mar 31, 2025 834.63 Mn
Dec 31, 2024 854.23 Mn
Sep 30, 2024 841.04 Mn
Jun 30, 2024 793.62 Mn
Mar 31, 2024 747.71 Mn
Dec 31, 2023 707.37 Mn
Sep 30, 2023 661.18 Mn
Jun 30, 2023 614.92 Mn
Mar 31, 2023 596.43 Mn
Dec 31, 2022 607.95 Mn
Sep 30, 2022 643.51 Mn
Jun 30, 2022 674.30 Mn
Mar 31, 2022 669.85 Mn
Dec 31, 2021 666.88 Mn
Sep 30, 2021 679.66 Mn